Novo Nordisk is going after compounding pharmacies in federal court again, filing three lawsuits in Florida and one in Tennessee Thursday, accusing the companies of illegally marketing and selling drugs that they claim contain semaglutide.
The new lawsuits come on the heels of an initial five lawsuits Novo Nordisk filed two weeks ago and builds on its promise to continue to pursue illegal semaglutide compounders.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters